UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003956
Receipt number R000004744
Scientific Title Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.
Date of disclosure of the study information 2010/08/05
Last modified on 2014/08/22 11:58:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.

Acronym

Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.(J-CIRCLE)

Scientific Title

Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.

Scientific Title:Acronym

Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.(J-CIRCLE)

Region

Japan


Condition

Condition

Essential Hypertension

Classification by specialty

Medicine in general Cardiology Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of Cilnidipine on the blood pressure and renal function.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1.Office blood pressure
2.Home blood pressure
3.Urinary albumin excretion

Key secondary outcomes

1.Heart rate
2.Serum uric acid
3.Adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of Cilnidipine

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Administration of amlodipine more than three months,and urinary albumin qualitative is positivity(1+ and above) of hypertensive patients.

Key exclusion criteria

Following patients will be excluded from this study.
1.Pregnant women or suspected of being pregnant.
2.Severe liver dysfunction.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Uchida shunya

Organization

Teikyo University School of Medicine

Division name

Internal medicine

Zip code


Address

2-11-1,kaga,Itabashi-ku,Tokyo

TEL

03-3964-1211

Email

s_uchida@netjoy.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Uchida shunya

Organization

Teikyo University School of Medicine

Division name

Internal medicine

Zip code


Address

2-11-1,kaga,Itabashi-ku,Tokyo

TEL

03-4964-1211

Homepage URL


Email

s_uchida@netjoy.ne.jp


Sponsor or person

Institute

Teikyo University

Institute

Department

Personal name



Funding Source

Organization

Teikyo University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

This study assessed the urinary albumin/creatinine ratio and uric acid metabolism in 70 hypertensive patients with CKD in whom the urinary albumin/creatinine ratio had remained  30 mg/g under the treatment of L-type calcium channel blocker amlodipine. Three months after switching to N/L-type calcium channel blocker cilnidipine, blood pressure did not change. However, urinary albumin/creatinine ratio significantly decreased by cilnidipine. Serum uric acid levels showed no significant change. In cases where uric acid production had been high (urinary uric acid/creatinine ratio  0.5), the urinary uric acid/creatinine ratio decreased significantly after cilnidipine treatment, suggesting that cilnidipine can suppress excessive uric acid formation. These results suggest that switching from amlodipine to cilnidipine resulted in a significant reduction in urinary albumin/creatinine ratio as well as significant reduction in uric acid production. Thus cilnidipine is more useful than amlodipine in improving albuminuria and uric acid metabolism in hypertensive patients with CKD.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 01 Month 28 Day

Date of IRB


Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2011 Year 10 Month 31 Day

Date of closure to data entry

2011 Year 12 Month 31 Day

Date trial data considered complete

2011 Year 12 Month 31 Day

Date analysis concluded

2012 Year 03 Month 31 Day


Other

Other related information

Journal: Journal of Clinical Hypertension

Article title: "Effects of the N/L-Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients with Chronic Kidney Disease (J-CIRCLE Study)."


Management information

Registered date

2010 Year 07 Month 27 Day

Last modified on

2014 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004744


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name